-
The implementation of the new policy promotes the development of TCM granule industry in China
On February 10, 2021, the State Drug Administration, the State Bureau of Traditional Chinese Medicine, the National Health Commission and the National Health Insurance Bureau jointly issued the Announcement on the End of the Pilot Work of Chinese Medicine Formula Granules, which came into effect in November. With the end of the pilot work of TCM granules, the relaxation of production and sales restrictions, and the acceleration of the filing of national and provincial standards, domestic TCM granule industry has ushered in new opportunities.
Learn more16 / 2022.12 -
A large number of Chinese medicine granules will be covered in the medical insurance!
From November, a large number of Chinese medicine granules will be covered into the medical insurance in major province of medicine.
Learn more16 / 2022.12 -
100 billion TCM granule market will expand
After long-term national policy guidance and support, the TCM granule industry is gradually moving towards standardization. As of early September 2022, the State Drug Administration released a total of 219 national standards for formula granules in four batches, and the increase of national standard varieties in the future is also an inevitable trend. In addition, on August 31, the State Medical Insurance Bureau launched the unified code for formula granules for medical insurance, a move that will further promote the standardization and standardization of the TCM granule industry, achieve traceability of supervision, and accelerate the standardization of medical insurance payment standards in the national market.
Learn more16 / 2022.12 -
Shandong: Chinese medicine reimbursement ratio will not be less than 85%, 1374 kinds of Chinese medicine, 892 kinds of Chinese medicine will be included in the medical insurance
Standardizing the medical insurance payment for Chinese medicine herbal pieces and therapeutic medical institutions, and included 1,374 types of Chinese patent medicines will include 892 types of Chinese medicine herbal pieces, 3,757 Chinese medicine granule products and eligible therapeutic Chinese medicine in-hospital preparations.
Learn more01 / 2022.12 -
Chinese medicine market may usher in a new round of reshuffle. Promoting the standardization of industry development will become the new focus of pharmaceutical companies
Under the background of digital change sweeping through the Chinese medicine industry, many Chinese medicine companies are also making great efforts to accelerate the transformation and upgrading with the help of digital technology and equipment to promote the high-quality development of pharmaceuticals.
Learn more01 / 2022.12